Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis, on the first day of Fall Dermatology Week 2023.
Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis, on the first day of Fall Dermatology Week 2023.
Jeffrey M. Cohen, MD, discussed...